The global in vivo CRO market size was estimated at USD 4.59 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030. The increasing burden of cancer patients, growing in vivo pharmacology studies, and the emerging number of pharma and biotechnology companies focusing on researching and developing novel therapeutics are...

The global Oncology Clinical Trials Market had a size of USD 8.43 billion in 2022. It is projected to expand and reach USD 12.75 billion by 2032, with a forecasted revenue Compound Annual Growth Rate (CAGR) of 4.7%. This growth is primarily fueled by several factors, including the rising incidence of cancer, a growing demand for personalized medicine, and an increasing need for innovative and...

The global market for transdermal drug delivery systems reached a value of USD 7.5 billion in 2022 and is projected to reach USD 10.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.8% expected during the forecast period. Key drivers of this market growth include the increasing prevalence of chronic illnesses, the adoption of advanced technologies by leading industry players,...